BridgeBio Oncology Therapeutics, Inc. - BBOT

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 29
Latest filed: Oct 05, 2026
Form Count
4 22
8-K 6
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Oct 05, 2026 4 Oct 01, 2026 0001193125-26-414123 View
Oct 05, 2026 4 Oct 01, 2026 0001193125-26-414127 View
Oct 05, 2026 4 Oct 01, 2026 0001193125-26-414131 View
Oct 05, 2026 4 Oct 01, 2026 0001193125-26-414135 View
Sep 14, 2026 4 Sep 10, 2026 0001193125-26-390624 View
Sep 08, 2026 8-K Sep 08, 2026 0001193125-26-385225 View
Aug 11, 2026 8-K Aug 11, 2026 0001193125-26-344608 View
Jul 06, 2026 4 Jul 01, 2026 0001193125-26-296501 View
Jul 06, 2026 4 Jul 01, 2026 0001193125-26-296503 View
Jul 06, 2026 4 Jul 01, 2026 0001193125-26-296504 View
Jul 06, 2026 4 Jul 01, 2026 0001193125-26-296502 View
Jul 06, 2026 4 Jul 01, 2026 0001213900-26-075538 View
Jul 06, 2026 SCHEDULE 13D/A — 0001213900-26-075546 View
Jun 22, 2026 8-K Jun 16, 2026 0001193125-26-277513 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276033 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276035 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276041 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276043 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276046 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276048 View
Jun 18, 2026 4 Jun 16, 2026 0001193125-26-276050 View
May 12, 2026 8-K May 12, 2026 0001193125-26-219801 View
May 12, 2026 4 May 10, 2026 0001193125-26-219447 View
May 12, 2026 4 May 10, 2026 0001193125-26-219439 View
May 05, 2026 4 Apr 01, 2026 0001193125-26-207041 View
May 05, 2026 4 Apr 01, 2026 0001193125-26-207035 View
May 05, 2026 4 Apr 01, 2026 0001193125-26-207031 View
Apr 29, 2026 8-K Apr 27, 2026 0001193125-26-191512 View
Apr 23, 2026 8-K Apr 20, 2026 0001193125-26-170888 View